CRISPR/Cas9

被引:4
|
作者
Mizuno, Naoaki [1 ]
Mizutani, Eiji [1 ]
Sato, Hideyuki [1 ]
Kasai, Mariko [1 ]
Nakauchi, Hiromitsu [1 ,2 ]
Yamaguchi, Tomoyuki [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Minato Ku, Tokyo, Japan
[2] Stanford Univ, Sch Med, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA
来源
BIO-PROTOCOL | 2019年 / 9卷 / 13期
关键词
CRISPR/Cas9; Adeno-associated viral vector; Trans-zona pellucida; Intra-embryo genome editing; Ribonucleoprotein electroporation; Large fragment knock-in; ELECTROPORATION;
D O I
10.21769/BioProtoc.3295
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intra-embryo genome editing by CRISPR/Cas9 has enabled rapid generation of gene knockout animals. However, large fragment knock-in directly into embryos' genome is still difficult, especially without microinjection of donor DNA. Viral vectors are good transporters of knock-in donor DNA for cell lines, but seemed unsuitable for pre-implantation embryos with zona pellucida, glycoprotein membrane surrounding early embryos. We found adeno-associated virus (AAV) can infect zygotes of various mammals through intact zona pellucida. AAV-mediated donor DNA delivery following Cas9 ribonucleoprotein electroporation enables large fragment knock-in without micromanipulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
  • [2] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888
  • [3] CRISPR/Cas9 as a Mutagenic Factor
    Shumega, Andrey R.
    Pavlov, Youri I.
    Chirinskaite, Angelina V.
    Rubel, Aleksandr A.
    Inge-Vechtomov, Sergey G.
    Stepchenkova, Elena I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [4] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [5] CRISPR/Cas9 in Gastrointestinal Malignancies
    Jefremow, Andre
    Neurath, Markus F.
    Waldner, Maximilian J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [6] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193
  • [7] Conditional Control of CRISPR/Cas9 Function
    Zhou, Wenyuan
    Deiters, Alexander
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (18) : 5394 - 5399
  • [8] CRISPR/Cas9 in allergic and immunologic diseases
    Goodman, Michael A.
    Manesh, Donya Moradi
    Malik, Punam
    Rothenberg, Marc E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 5 - 9
  • [9] CRISPR/Cas9 genome editing in wheat
    Dongjin Kim
    Burcu Alptekin
    Hikmet Budak
    Functional & Integrative Genomics, 2018, 18 : 31 - 41
  • [10] Application of CRISPR/Cas9 technology in forages
    Bao, Qinyan
    Wolabu, Tezera W.
    Zhang, Qian
    Zhang, Tian
    Liu, Zhipeng
    Sun, Juan
    Wang, Zeng-Yu
    GRASSLAND RESEARCH, 2022, 1 (04): : 244 - 251